Department of Health and Social Care (DHSC) has issued a medicine supply notification for Pabrinex® (Vitamins B and C) Intravenous and Intramuscular High Potency solution
for injection ampoules.
MSN/2024/038
Tier 3 – high impact
Date of issue: 3rd April 2024
Pabrinex® Intravenous (IV) injection will be out of stock from August 2024 until at least September 2025.
Pabrinex® Intramuscular (IM) injection is being discontinued, with stock exhaustion expected from December 2024.
There are no other licensed parenteral alternatives to Pabrinex® IV and IM injections.
Thiamine 50mg and 100mg tablets remain available and should be used where clinically appropriate.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Pabrinex® (Vitamins B and C) Intravenous and Intramuscular High Potency solution for injection ampoules appeared first on Community Pharmacy England.